Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism 30S subunit inhibitors(30S ribosomal subunit inhibitors), DHFR inhibitors(Dihydrofolate reductase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (01 Jan 1995), |
Regulation- |
Molecular FormulaC14H18N4O3 |
InChIKeyIEDVJHCEMCRBQM-UHFFFAOYSA-N |
CAS Registry738-70-5 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Infectious Diseases | China | 01 Jan 1995 | |
| Escherichia Coli Infections | China | - | - |
| Gram-Negative Bacterial Infections | China | - | - |
| Gram-Positive Bacterial Infections | China | - | - |
| Pseudomonas Infections | China | - | - |
| Staphylococcal Infections | China | - | - |





